Catalyst Funds Management Pty LTD Ikena Oncology, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,500 shares of IKNA stock, worth $7,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,500Holding current value
$7,830% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
63Shares Held
30.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.73 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.3 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$7.12 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$6.16 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.91 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $63.1M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...